Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Mats Josefson in Pharmaceutical Analysis
Introduction
Mats Josefson, an esteemed inventor based in Mölndal, Sweden, has made significant strides in the field of pharmaceutical analysis. With one patent to his name, Josefson stands out for his innovative approach to tackling challenges in examining turbid pharmaceutical samples.
Latest Patents
Josefson's notable patent, titled "Method and apparatus for spectrometric analysis of turbid, pharmaceutical samples," offers an advanced methodology for the quantitative analysis of turbid pharmaceutical substances, such as tablets and capsules. This invention utilizes a unique method where a pharmaceutical sample is irradiated with an excitation beam, specifically near-infrared radiation. The emitted radiation's intensity is then detected, revealing essential data regarding its wavelength and photon propagation time through the sample. Additionally, the invention allows for the spatially resolved detection of emitted radiation, enhancing the accuracy of the analysis.
Career Highlights
Mats Josefson's career is marked by a commitment to innovation and problem-solving within the pharmaceutical sector. His work at AstraZeneca AB, a leading global biopharmaceutical company, reflects his dedication to advancing the understanding and analysis of complex pharmaceutical formulations.
Collaborations
Throughout his career, Josefson has collaborated with esteemed colleagues such as Staffan Folestad and Anders Sparén. These partnerships have fostered an environment of creativity and shared expertise, contributing to the development of groundbreaking techniques in pharmaceutical analysis.
Conclusion
Mats Josefson’s invention represents a pivotal advancement in the analysis of turbid pharmaceutical samples. His dedication and innovative spirit continue to influence the field, highlighting the importance of creativity and collaboration in driving progress in pharmaceutical research and development.